Pay in 4 interest-free payments of $6.83 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
A few important notes about this table
Patients with T2D not adequately controlled on therapy with metformin and insulin glargine as baseline therapy received either tirzepatide at the doses used in the SURPASS trials or placebo during the 40-week study setting
More visceral fat worsens insulin resistance
We obtained the companies financials via the Securities and Exchange Commissions EDGAR database of corporate filings
People who used aggressive weight loss medications or crash diets may face more significant laxity than those who lost weight steadily over a longer period
US$ 23.42
US$ 23.98
US$ 28.68
US$ 27.10
